Travel-Imported Arbovirus infections and mHealth applications for outbreak Risk Assessment: ZIeKA monitor part 2

Completed

• Conditions: arbovirus infections; mosquito-born infections; 10047438

• Registration Number: NL-OMON48637
• Lead Sponsor: RIVM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-06-10
• Results First Posted: 2022-09-16
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 239

Inclusion Criteria

adult travelers, traveling to areas with risk of arbovirus infections.These
adult travelers are participants of part one of the ZIeKA monitor.

Exclusion Criteria

not willing to collect blood with finger prick

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The proportion of PCR positive samples containing arboviruses (Dengue,<br /><br>Chikungunya, Zika, Gele koorts) in travelers.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The proportion of positive serology samples of arbovirus (Dengue, Chikungunya,<br /><br>Zika, Gele koorts) specific IgM en/of IgG in travelers who developed health<br /><br>complaints during their trip.</p><br>